China Resources Boya Bio pharmaceutical Group Co Ltd (300294) — Cash Flow-to-Debt Ratio
China Resources Boya Bio pharmaceutical Group Co Ltd (300294) has a Cash Flow-to-Debt Ratio of 0.03x as of December 2025, meaning its operating cash flow of CN¥36.82 Million could theoretically repay 0% of its total liabilities (CN¥1.16 Billion) in one year. See cash generation quality of China Resources Boya Bio pharmaceutical to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
China Resources Boya Bio pharmaceutical Group Co Ltd Cash Flow-to-Debt Ratio (2009–2025)
Historical debt coverage capacity for China Resources Boya Bio pharmaceutical Group Co Ltd across 17 annual periods. Also explore 300294 net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for China Resources Boya Bio pharmaceutical Group Co Ltd (2009–2025)
Year-by-year debt coverage analysis for China Resources Boya Bio pharmaceutical Group Co Ltd. For market capitalisation and broader financial context, see China Resources Boya Bio pharmaceutical market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | CN¥116.69 Million | CN¥1.16 Billion | ▼ -69.5% |
| 2024 | 0.33x | CN¥299.78 Million | CN¥913.38 Million | ▼ -74.0% |
| 2023 | 1.26x | CN¥641.73 Million | CN¥508.07 Million | ▲ +58.5% |
| 2022 | 0.80x | CN¥596.44 Million | CN¥748.35 Million | ▼ -58.5% |
| 2021 | 1.92x | CN¥1.35 Billion | CN¥701.30 Million | ▲ +157.9% |
| 2020 | 0.74x | CN¥718.58 Million | CN¥966.08 Million | ▲ +923.7% |
| 2019 | -0.09x | CN¥-114.51 Million | CN¥1.27 Billion | ▼ -437.0% |
| 2018 | 0.03x | CN¥34.90 Million | CN¥1.30 Billion | ▲ +233.4% |
| 2017 | -0.02x | CN¥-23.82 Million | CN¥1.19 Billion | ▼ -102.9% |
| 2016 | 0.69x | CN¥198.76 Million | CN¥287.30 Million | ▲ +31.8% |
| 2015 | 0.52x | CN¥147.02 Million | CN¥280.11 Million | ▼ -59.6% |
| 2014 | 1.30x | CN¥121.88 Million | CN¥93.90 Million | ▲ +129.9% |
| 2013 | 0.56x | CN¥89.11 Million | CN¥157.85 Million | ▼ -84.2% |
| 2012 | 3.58x | CN¥92.36 Million | CN¥25.80 Million | ▲ +200.7% |
| 2011 | 1.19x | CN¥81.53 Million | CN¥68.48 Million | ▲ +370.1% |
| 2010 | 0.25x | CN¥24.77 Million | CN¥97.79 Million | ▼ -25.8% |
| 2009 | 0.34x | CN¥51.88 Million | CN¥151.93 Million | — |